Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Bavarian Nordic Announces Start of EBOVAC-Salone Trial for Ebola Vaccine Biosecurity October 9, 2015 …
Positive Results for Arno Therapeutics’ Broad Spectrum Antimicrobial Biosecurity September 20, 2015 …
Countermeasures: Antibiotic Combo Kills Resistant Staph Antimicrobial Resistance September 16, 2015 …
